Money Concepts Capital Corp Dexcom Inc Transaction History

Money Concepts Capital Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 27, 2022	SELL	$76.35 - $94.18 $3,664 - $4,520	-48 Reduced 4.96%	920 $74,000
Q2 2022 Jul 18, 2022	BUY	$67.99 - $132.89 $48,000 - $93,820	706 Added 269.47%	968 $75,000
Q1 2022 May 13, 2022	BUY	$94.08 - $130.2 $24,648 - $34,112	262 New	262 $134,000
Q4 2021 Feb 14, 2022	SELL	$129.87 - $162.82 $223,376 - $280,050	-1,720 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$84.79 - $104.74 $2,628 - $3,246	-31 Reduced 1.77%	1,720 $618,000
Q4 2020 May 17, 2021	BUY	$78.0 - $104.5 $136,578 - $182,979	1,751 New	1,751 $647,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Money Concepts Capital Corp, based on Form 13F filings with the SEC.

Stay updated on Money Concepts Capital Corp with notifications on news.